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Monosomy 1p36 is the most common subtelomeric microdeletion syndrome with an incidence rate estimated to be 1 in 5000
births. A hypothesis of a similarity between patients with 1p36 deletion and those with Prader-Willi syndrome and the existence
of two different phenotypes for 1p36 microdeletion has been suggested. The main objective of the present study was to
determine the existence of 1p36 microdeletion in a sample of patients with mental retardation, obesity and hyperphagia who
tested negative by the methylation test for Prader-Willi syndrome. Sixteen patients (7 females, 9 males), 16-26 years old, were
evaluated with high-resolution cytogenetic analysis at 550-850 band levels and with 11 polymorphic microsatellite markers
located in the 1p36 region. All patients had normal cytogenetic and molecular results. The results obtained by high-resolution
cytogenetic methodology were confirmed by the molecular analyses. We did not detect a 1p36 microdeletion in 16 subjects with
the Prader-Willi-like phenotype, which reinforces that no correlation seems to exist between Prader-Willi-like phenotype and the
1p36 microdeletion syndrome.
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We tested for the 1p36 microdeletion in 16 patients (16-
26 years old) with the Prader-Willi-like phenotype who
tested negative for the Prader-Willi syndrome using the
methylation test by Southern blot with the Kb17 probe (1).
Clinical characterization of the patients (Table 1) was
performed using a protocol with the characteristics of
Prader-Willi phenotype and 1p36 microdeletion syndrome
based on the literature (2-11). The protocol was approved
by the institutional Ethical Review Board and written in-
formed consent was obtained from the parents of all pa-
tients. Twelve patients were examined by the authors, and
the other 4 were studied by the University Hospital of Rio
Grande do Sul (Porto Alegre, RS, Brazil).
Two methods were used to identify the 1p36 microde-
letion. First, the high-resolution 1p36 cytogenetic region
studies. For this, we obtained metaphases from phytohe-
magglutinin-stimulated peripheral blood lymphocytes us-
ing the methotrexate and thymidine synchronization meth-
od (12) with GTG banding for cytogenetic analysis per-
formed at 550-850 band levels. We analyzed 40 meta-
phases for each patient. The levels reached to exclude
mosaics were ≤6% for a confidence interval of 99%, and ≤8
and ≤11% for 95 and 90% confidence intervals, respec-
tively (13). Secondly, polymorphic markers of the 1p36
region were analyzed using 11 dinucleotide or tetranucle-
otide polymorphisms (D1S243, D1S468, D1S2660,
D1S2795, D1S2870, D1S2145, D1S214, D1S2663,
D1S450, D1S244, D1S2667). For this assessment, we
collected blood samples from patients and their parents
and extracted genomic DNA by a standard method, and
later performed amplification in a volume of 15 µL with 50
ng genomic DNA, 6 pmol of each primer, and 0.5 unit of
thermostable DNA polymerase in a buffer containing 10
mmol/L Tris-HCl, pH 8.3, 50 mmol/L KCl, 1.5 mmol/L
MgCl2, and 100 µmol/L of each dNTP, and 0.2 µL 32-P
dNTP was added per reaction. Thirty-one amplification
cycles were used with 35 s at 95°C, 35 s at 55-62°C for
primer annealing, and 35 s at 72°C for extension. Products
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After the high-resolution cytogenetic analysis, no subte-
lomeric deletion in the 1p36 region was observed in 40
metaphases for each patient. All 11 dinucleotide and tetra-
nucleotide repeat polymorphic markers for each family were
negative for 1p36 microdeletions. In cases of homozygosity
in one marker, the heterozygosity of other markers was used
to indicate lack of deletion (Figure 1).
Our patient sample (Table 1) was consist-
ent with the Prader-Willi-like phenotype be-
cause 100% had mental retardation associ-
ated with obesity and hyperphagia, and a high
prevalence of other important signs of Prader-
Willi syndrome, i.e., developmental delay (81%),
hypotonia (94%), infant feeding problems
(94%), abusive behavior (75%), and other as-
sociated dysmorphic features.
The number and position of the polymor-
phic markers in the 1p36 region used are lo-
cated in all six intervals of the microdeletion
distribution, as suggested by Wu et al. (14) and
observed by Heilstedt et al. (11). Furthermore,
we used two polymorphic markers (D1S243
and D1S468) mapped inside the obesity/hyper-
phagia chromosomal segment 1p36.33-36.32
suggested by D’Angelo et al. (15). All results
obtained in the polymorphic marker analyses in
our patient sample were normal. On the other
hand, all 40 metaphases analyzed by the high-
resolution technique were also normal, reveal-
ing a correspondence between cytogenetic and
molecular analysis and reinforcing the obser-
vation of Heilstedt et al. (16) that 98% of this
microdeletion could be detected by high-reso-
lution chromosome analysis.
Slavotinek et al. (8) reviewed 39 cases re-
ported to have pure 1p36 deletion and only 2
cases (5.1%) had the Prader-Willi-like pheno-
type. Shapira et al. (7) described 13 cases of
the pure 1p36 deletion and 2 cases (15%) had
obesity. D’Angelo et al. (15) have described 1
case of pure 1p36 deletion within a group of 41
cases with Prader-Willi-like phenotype. The
phenotype defined as monosomy 1p36 by
Heilstedt et al. (11) excluded hyperphagia/obe-
sity and the relationship between this microde-
letion syndrome and the Prader-Willi-like phe-
notype. Our results do not confirm the sugges-
tion of D’Angelo et al. (15) about a specific
hyperphagia/obesity chromosomal region in
1p36 but reinforce the opinion of Heilstedt et al.
(11).
Figure 1. Polymorphic marker analysis for 1p36 deletion. Analyses of three
chromosome 1p36 markers are shown (D1S243, D1S468 and D1S2145) for
patient 8 (P = patient, F = father, M = mother). The allelic distribution was
considered to be normal.
were separated on 6% polyacrylamide/urea gels and ana-
lyzed based on mapping data obtained from <http://www.
Ensembl.org/Homo_sapiens> for chromosome 1. In order to
establish which polymorphic loci were deleted, alleles were
compared between the patient and their parents.
Table 1. Clinical characteristics of Prader-Willi phenotype and specific char-
acteristics of 1p36 microdeletion syndrome observed in 16 patients using a
protocol based on the literature (2-11).
Clinical characteristics of Prader-Willi phenotype Number of patients (%)
Developmental delay 13/16 (81%)
Mental retardation 16/16 (100%)
Hypotonia 15/16 (94%)
Obesity 16/16 (100%)
Before 6 years of age 9/16 (56%)
After 6 years of age 7/16 (44%)
Hyperphagia 16/16 (100%)
Before 6 years of age 9/16 (56%)
After 6 years of age 7/16 (44%)
Infant feeding problems 15/16 (94%)
Hypogonadism 2/16 (13%)
Hypogenitalism 4/16 (25%)
Small hands 4/16 (25%)
Small feet 5/16 (31%)
Down-turned mouth 3/16 (19%)
Middle face hypoplasia 6/16 (38%)
Sleeping disturbance 1/16 (6%)
Strabismus 4/16 (25%)
Abusive behavior 12/16 (75%)
Specific clinical characteristics of 1p36 Number of patients (%)
monosomy present in our patients
Large anterior fontanel 4/16 (25%)
Middle face hypoplasia 6/16 (38%)
Short fifth finger 3/16 (19%)
Fifth finger clinodactyly 4/16 (25%)
Strabismus 4/16 (25%)
Hypothyroidism 1/16 (6%)
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Shaffer and Heilstedt (17) affirm that the phenotype of
1p36 monosomy is very characteristic with high similarities
among the patients. If we consider that obesity is a very
common clinical sign associated with mental retardation,
and that it is now a public health problem, we question if
these patients, who were described as being obese, are
really representative of this microdeletion syndrome.
